In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

Item

http://www.wikidata.org/entity/Q40283050

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

@en

type

Item

label

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

@en

prefLabel

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

@en

P1476

In Vitro Susceptibility Testing of Tedizolid against Nontuberculous Mycobacteria.

@en

P2093

Barbara A Brown-Elliott

http://www.w3.org/2001/XMLSchema#string

Richard J Wallace

http://www.w3.org/2001/XMLSchema#string

P2860

Activities of linezolid against rapidly growing mycobacteria.

Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug

Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers

In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.

Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.

Tedizolid (TR-701): a new oxazolidinone with enhanced potency.

Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate.

Tedizolid for the management of human infections: in vitro characteristics.

P304

1747-1754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00274-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28330892

http://www.w3.org/2001/XMLSchema#string

P932

5442531

http://www.w3.org/2001/XMLSchema#string